HYG | PHYL | HYG / PHYL | |
Gain YTD | 7.342 | 8.216 | 89% |
Net Assets | 19.9B | 484M | 4,112% |
Total Expense Ratio | 0.49 | 0.39 | 126% |
Turnover | 14.00 | 47.00 | 30% |
Yield | 5.70 | 7.55 | 75% |
Fund Existence | 19 years | 7 years | - |
HYG | PHYL | |
---|---|---|
RSI ODDS (%) | 1 day ago30% | 1 day ago38% |
Stochastic ODDS (%) | 1 day ago39% | 1 day ago39% |
Momentum ODDS (%) | 1 day ago52% | 1 day ago44% |
MACD ODDS (%) | 1 day ago50% | 1 day ago37% |
TrendWeek ODDS (%) | 1 day ago55% | 1 day ago58% |
TrendMonth ODDS (%) | 1 day ago51% | 1 day ago54% |
Advances ODDS (%) | 9 days ago55% | 6 days ago61% |
Declines ODDS (%) | 5 days ago52% | 13 days ago50% |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 1 day ago46% | 1 day ago49% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
USCA | 41.56 | 0.27 | +0.66% |
Xtrackers MSCI USA Clmt Actn Eq ETF | |||
LODI | 25.28 | -0.02 | -0.10% |
AAM SLC Low Duration Income ETF | |||
SDS | 14.24 | -0.10 | -0.70% |
ProShares UltraShort S&P500 | |||
FTXH | 29.46 | -0.23 | -0.76% |
First Trust Nasdaq Pharmaceuticals ETF | |||
RSPR | 34.99 | -0.50 | -1.41% |
Invesco S&P 500® Equal Wt Real Estt ETF |
A.I.dvisor tells us that PHYL and EXE have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHYL and EXE's prices will move in lockstep.
Ticker / NAME | Correlation To PHYL | 1D Price Change % | ||
---|---|---|---|---|
PHYL | 100% | N/A | ||
EXE - PHYL | 20% Poorly correlated | +0.27% | ||
OXY - PHYL | 12% Poorly correlated | +1.23% | ||
CIVI - PHYL | 12% Poorly correlated | -1.61% |